Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein AI-containing lipoprotein particles-Reference-Cited by-同舟云学术

Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein AI-containing lipoprotein particles

Published:2000-10 Issue:2 Volume:152 Page:433-440
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Adlouni Ahmed,El Messal Mariame,Saı̈le Rachid,Parra Henri-Joseph,Fruchart Jean-Charles,Ghalim Noredine

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference47 articles.

1. Plasma high-density lipoprotein concentration and development of ischemic heart disease;Miller;Lancet,1975

2. High density lipoprotein as protective factor against coronary heart disease: the Framingham study;Gordon;Am. J. Med.,1977

3. Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells;Barkia;Atherosclerosis,1991

4. High-density lipoprotein and reverse cholesterol transport;Barter;Curr. Opin. Lipidol.,1993

5. Hypocholesterolemic effect of 4,4′-(isopropylidenedithio) bis(2,6-di-t-bytylphenol) (Probucol);Barnhart;Am. J. Clin. Nutr.,1970

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases;Translational Neurodegeneration;2024-01-22

2. High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells;Frontiers in Cardiovascular Medicine;2022-04-26

3. Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophages;BBA Advances;2021

4. HDL functionality in familial hypercholesterolemia: effects of treatment modalities and pharmacological interventions;Drug Discovery Today;2018-01

5. Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease;Journal of Atherosclerosis and Thrombosis;2016